Everolimus is a mechanistic/mammalian target of rapamycin (mTOR) inhibitor and is thought to inhibit tumor growth directly and indirectly by suppressing the proliferative signals of the PI3K/AKT/mTOR signaling pathway [12]. This evidence concerns the gene MTOR and neoplasm.